Shanghai, China

Yvonne Angell

This inventor holds 4 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignees: Xdcexplorer (Shanghai) Co., Ltd., Shangpharma Innovation Inc.. Active years: 2022-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yvonne Angell. Retrieved from https://idiyas.com/inventor/yvonne-angell

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.4

ph-index = 1


Company Filing History:


Years Active: 2022-2024

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Yvonne Angell: Innovator in Peptide Compounds

Introduction

Yvonne Angell is a prominent inventor based in Shanghai, China. She has made significant contributions to the field of peptide compounds, holding a total of 4 patents. Her work focuses on the development of innovative compounds with pharmaceutical applications.

Latest Patents

Yvonne Angell's latest patents include a peptide compound, its application, and a composition containing the same. The first patent discloses a peptide compound represented by a specific formula, along with its pharmaceutically acceptable salts, tautomers, solvates, crystal forms, or prodrugs. This compound is noted for its good stability and activity. Another patent details a peptide compound named YA-156, which also includes various forms and is recognized for its stability and activity for Kiss1R. Additionally, she has developed a complex peptide sequence that showcases her innovative approach to peptide design.

Career Highlights

Throughout her career, Yvonne Angell has worked with notable companies such as Xdcexplorer (Shanghai) Co., Ltd. and Shangpharma Innovation Inc. Her expertise in peptide compounds has positioned her as a key player in the pharmaceutical industry.

Collaborations

Yvonne has collaborated with talented individuals in her field, including Yan Wang and Yonghan Hu. These partnerships have contributed to her success and the advancement of her research.

Conclusion

Yvonne Angell's contributions to the field of peptide compounds highlight her innovative spirit and dedication to advancing pharmaceutical science. Her patents reflect her commitment to developing effective and stable compounds for medical applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…